VYNE Therapeutics (VYNE) Exchange Rate Effect (2019 - 2021)
VYNE Therapeutics (VYNE) posted Exchange Rate Effect of -$1000.0 for Q2 2021, down 200.0% on a QoQ basis from $1000.0 in Q1 2021, and down 102.63% year-over-year from $38000.0 in Q2 2020.
VYNE Therapeutics (VYNE) Exchange Rate Effect (2019 - 2021) Analysis & Trends
VYNE Therapeutics' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at -$1000.0 for Q2 2021.
- Quarterly Exchange Rate Effect fell 102.63% year-over-year to -$1000.0 in Q2 2021, while the trailing twelve-month figure through Mar 2022 was -$1000.0 (down 102.56% YoY) and the FY2020 annual result came in at $1000.0, down 97.56% from the prior year.
- Exchange Rate Effect was -$1000.0 for Q2 2021 at VYNE Therapeutics, down from $1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $38000.0 in Q2 2020 and bottomed at -$37000.0 in Q1 2020.
- A 3-year average of $5250.0 and a median of $7000.0 in 2019 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2020 — Exchange Rate Effect slumped 384.62% — and 2021, when it jumped 102.7%.
- VYNE Therapeutics' Exchange Rate Effect stood at $16000.0 in 2019, then soared by 137.5% to $38000.0 in 2020, then tumbled by 102.63% to -$1000.0 in 2021.
- Business Quant data shows VYNE's Exchange Rate Effect at -$1000.0 in Q2 2021, $1000.0 in Q1 2021, and $38000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Jun 30, 2019 | 35,000.00 |
| Jun 30, 2019 | 35,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |